We describe in this report the development of disseminated intravascular coagulopathy in a neonate after transtorcular embolization of an unusual vein of Galen aneurysm. This rare but potentially fatal complication associated with transtorcular embolization should be considered in decision-making and prognostic evaluation processes, especially in neonates with severe heart failure.
Vein of Galen aneurysm is a rare congenital anomaly of the cerebral circulation. However, neonatal and prenatal diagnoses have increased since the development of noninvasive imaging techniques. Neonatal presentation usually includes high-output congestive heart failure secondary to increased volume and pressure overload on the myocardium. 1 This condition is often refractory to medical management, and a more invasive therapeutic approach is required to reduce the vascular "steal" phenomenon. Because of the low vascular resistance within the arteriovenous fistula (AVF), the majority of left ventricular output might be delivered to the head instead of the descending aorta (hence the term "steal"). Because no capillary network is present within the AVF, this output returns directly to the right ventricle, causing right heart failure from volume and work overload. Subsequently, the shunted blood is added to the lungs with consequent increased volume load to the left ventricle as well. Also, decreased blood flow in the descending aorta results in poor peripheral perfusion and metabolic acidosis. Finally, decreased afterload induced by the AVF increases the risk of myocardial ischemia. 1 Surgical management is often very difficult owing to the deep location of the malformation and the size of the patient. 2 Recently, endovascular embolization has emerged as the treatment of choice in neonates. 3, 4 An endovascular approach includes transfemoral arterial or venous embolization or transtorcular embolization. 3, 5, 6 To our knowledge, there has been only one reported case of severe coagulopathy after transtorcular embolization using Gianturco coils, which are large stainless steel coils interwoven with synthetic fibers and usually used with large catheters. Conversely, platinum coils are stainless steel microcoils that are used in smaller AVFs where microcatheters are needed to reach the fistulous track. In this report, we describe an unusual neonatal presentation of a vein of Galen aneurysm complicated by disseminated intravascular coagulopathy after transtorcular embolization using fibered and nonfibered platinum microcoils.
CASE REPORT
A 4310-gm, white male infant was born at 40 weeks of gestation by cesarean section after an uncomplicated pregnancy. He required resuscitation at birth because of poor respiratory effort, cyanosis, and poor perfusion with Apgar scores of 1, 3, and 5 at 1, 5, and 10 minutes, respectively. On physical examination, he was poorly perfused, had an active precordium with a gallop rhythm, a grade III/VI holosystolic murmur, and hepatomegaly. He was macrocephalic with a head circumference of 42 cm (Ͼ95th percentile), a full anterior fontanel, and split sagittal sutures of 1 cm. Skull auscultation revealed cranial bruits. He had poor tone, decreased spontaneous movements, and bilaterally fisted hands. A chest radiograph showed cardiomegaly with a large right pleural effusion. A cerebral arteriovenous malformation (AVM) with high-output cardiac failure was suspected. Cardiac ultrasound on the same day revealed severe right ventricular dilatation with increased pulmonary artery pressure, a right to left shunt through a patent foramen ovale, and significant diastolic runoff with an aortic steal phenomenon toward the cervical arteries. A helical CT scan of the head with CT angiography demonstrated an aneurysmally dilated vein of Galen with multiple AVFs at the superior vermian vein associated with hydrocephalus. Given the poor prognosis and the increased risk of surgery, expectant management with a "Do Not Resuscitate" order option was offered to the parents, who elected for intervention instead.
A surgical approach was felt to be fatal because of the nature and the location of the arteriovenous malformation, therefore a transtorcular embolization was attempted. Initial transarterial embolization through the femoral arteries was unsuccessful owing to the extreme tortuosity of the carotid and vertebral arteries. Cerebral angiography with injection of contrast media in the aortic arch demonstrated markedly dilated superior vermian vein, vein of Galen, falcine sinus,
and transverse sinus. Numerous AVFs were seen at the superior vermian vein (Figure 1 ). On day 4, the baby underwent transtorcular embolization using a direct surgical approach from the occipital area through the falcine sinus. A 4 French catheter was initially inserted into the falcine sinus through which a microcatheter was navigated into the superior vermian vein. A staged reduction by embolization of the arteriovenous flow shunt was performed. 4, 6 This avoids normal perfusion pressure breakthrough after complete obliteration of the vascular malformation, during which increased blood flow to previously hypoperfused peripheral brain tissue could result in brain edema, hemorrhage, and seizures. 4, 6 A total of 72 nonfibered platinum coils, 7 long-fibered platinum coils (20 to 30 ϫ 100 mm), and 65 fibered and nonfibered platinum coils of various smaller sizes was threaded through the microcatheter. Several nonfibered coils washed distally into the vein of Galen and the falcine sinus during the early part of the procedure as a result of the extremely high arteriovenous shunt flow. The procedure was terminated before achieving a significant reduction in the shunting flow because of systemic blood pressure elevation. This termination avoided an increased risk of intracranial bleeding. However, because the infant continued to experience worsening congestive cardiac failure and pulmonary edema, a second embolization was performed on day 6. An additional 72 fibered and nonfibered platinum coils of various sizes were inserted through a microcatheter in the superior portion of the vermian vein and the vein of Galen (Figure 2 ). The procedure was terminated after a reduction of 50% in the arteriovenous shunting as demonstrated by Doppler ultrasound of the head.
Medical management included ventilatory support and 100% oxygen administration, pleural drainage, and replacement of pleural fluid losses with albumin and fresh frozen plasma, inotropy (dopamine and digoxin), and a trial of nitroprusside for persistent highoutput cardiac failure. Following both embolization procedures, the baby was noted to have thrombocytopenia (platelet count 81,000 cells/mm 3 ), which was corrected by platelet transfusions. His coagulation profile remained within normal limits: prothrombin time of 14.2 seconds (normal: 10 to 15.3 seconds), partial thromboplastin time of 41 seconds (normal: 25.4 to 59.8 seconds), and fibrinogen concentration of 232 mg/dl (normal: 162 to 462 mg/dl). However, 12 hours after the second embolization, subcutaneous bleeding was noted over the pressure areas and extensive pulmonary hemorrhaging with desaturation and bradycardia developed. Despite aggressive medical management, the pulmonary hemorrhage could not be controlled; clinical deterioration continued over the next several hours and the patient died on day 7 of persistent disseminated intravascular coagulation. Blood levels for protein S, protein C, or antithrombin III deficiency were not obtained.
Autopsy findings confirmed the severe cardiac hypertrophy and cardiomegaly and numerous AVFs at the superior vermian vein with obstructive hydrocephalus. Acute mild subarachnoid hemorrhage and blood clots inside and between some vessels around the AVM were also evident. Finally, autopsy revealed bilateral extensive pulmonary hemorrhage, mostly intra-alveolar with focal infarction and thromboemboli. The pulmonary thromboemboli did not contain any coil material. 
DISCUSSION
The diagnosis of vein of Galen aneurysm, although rare, is being made more frequently during the perinatal period because of advanced imaging techniques. The prognosis of neonates with vein of Galen aneurysms remains very poor and depends in large part on the degree of blood shunting through the arteriovenous malformation. High-output congestive heart failure, resulting in massive cerebral or myocardial infarction, accounts for the high mortality in these infants. 7, 8 The goal of therapy is to reduce the flow through the fistula to decrease the steal phenomenon and improve organ perfusion.
Neurosurgical therapy to control the progressive cardiac failure may sometimes be possible, but results of this approach have not been encouraging with mostly poor outcomes seen. 1, 9 Recently, neuroradiologic techniques have improved the outcome for vein of Galen aneurysms. 4 Endovascular treatments include transarterial or transvenous embolization. A transfemoral or a transtorcular approach is often used in neonates. Various embolic agents have been used, although coils are the primary choice for transtorcular embolization. Acute or delayed intracranial bleeding during embolization may occur because of vein perforation, either directly by coil insertion or secondarily to a sudden increase in venous pressure after venous occlusion. 3, 5, 6 Mickle and Quisling, 6 who first reported the transtorcular embolization technique, recommended a two-stage embolization approach. The goal in stage I is to reduce the original shunt flow only by 50% to avoid normal perfusion pressure breakthrough. Complete elimination of the flow through the vein of Galen aneurysm is achieved in stage II. Normal perfusion pressure breakthrough secondary to complete obliteration of a vascular malformation results from increased blood flow to previously hypoperfused peripheral brain tissue and might produce brain edema, generalized venous thrombosis with venous infarction, intracranial hemorrhage, and seizures. 4, 6 In a recent review on vein of Galen aneurysms, Horowitz et al. 4 mentioned the possible occurrence of coagulopathy with intracranial hemorrhage as an unusual but potentially fatal complication of embolization. To date there has been only one report of disseminated coagulopathy following transtorcular embolization in the neonate. 7 Similar to our case, the two infants described developed severe disseminated intravascular coagulopathy after transtorcular embolization with Gianturco coils, although one of them had an abnormal coagulation profile that was corrected before the procedure. Gianturco coils have been used to occlude aneurysmal dilatation of the vein of Galen through the falcine sinus. 4 They are composed of stainless steel coils interwoven with synthetic fibers and are larger in size compared with platinum microcoils. In our case platinum microcoils were introduced through a microcatheter into the markedly dilated superior vermian vein. Platinum microcoils with or without fibers provide an adherent surface on which a thrombus forms leading to vessel occlusion. Platinum microcoils and Gianturco coils may have a similar local thrombogenic effect and risk of coagulopathy. In our case, although no abnormalities in the coagulation profile were seen, disseminated intravascular coagulopathy was clinically evident. Despite plasma transfusions given to replace pleural fluid losses, which might have altered laboratory results, the infant developed disseminated intravascular coagulopathy with subcutaneous and pulmonary hemorrhage. The most likely explanation for the consumptive coagulopathy was an excessive deposition of platelets and clotting factors on the surface of the coils. In addition, pre-existing hypoxemia resulting in multiorgan system failure put the infant at an increased risk for coagulopathy. 10 We feel that interventionalists who use these coils should be aware of the risk of severe coagulopathy with thrombocytopenia and that extensive embolization obliterating the fistulous communication during one session may be detrimental. Additionally, such complications should be taken into account in the decision-making process. This possible outcome should be presented to the parents.
